Early Cancer Detection.

Reliable Results.

Proactive screening to keep living your best life with early multi-cancer detection. *

*The EPISEEK™ test may not identify signals for every type of cancer at every stage. There is a possibility of false positive and false negative results.

The EPISEEK™ Test

From a simple blood draw, EPISEEK™ can detect 20 types of cancer, including early Stages, by examining specific cancer-related DNA methylation patterns unique to tumors, enhancing accurate detection.

LEARN MORE

Brain

Lung & Bronchus

Breast

Colon & Rectum

Prostate

Melanoma

Bladder

Kidney

Pancreas

Lymphoma

Uterine and Cervical

Thyroid

Oral

Liver

Esophagus

Ovarian

How It Works

EPISEEK™ redefines cancer detection and monitoring, identifying cancer with more specificity than imaging and by being more accessible than invasive tissue biopsies.

Provider Draws Blood

Test is Sent to Lab

Specimen is Analyzed

Provider Explains Results

Results in just 7-10 days.

LEARN MORE

Who is EPISEEK™ For?

The EPISEEK™ test is recommended for:

R

Those with an elevated risk of cancer.

R

Individuals aged 45 or older.

The EPISEEK™ test is not recommended for:

Individuals who are pregnant.
Individuals aged 21 years or younger.
Individuals undergoing active cancer treatment or those with an active known malignancy.

Talk to your healthcare provider about including the EPISEEK™ test as part of your annual checkup!

The Right Provider is Committed to Keeping You Healthy.

“As a physician, I know that early detection is critical in the fight against cancer. The EPISEEK™ liquid biopsy test is a groundbreaking tool that identifies cancer at its earliest stages, when it’s most treatable. I highly recommend Precision Epigenomics for its accuracy and its potential to save lives by catching cancer before symptoms begin. Not only do I order EPISEEK™ for my patients, but my healthcare provider also ordered it for me.”

– KRISTINE ROMINE, MD